Thursday, Aug 24 2017 | Time 08:26 Hrs(IST)
image
  • Civilians under greater threat as Raqqa fight intensifies: Amnesty
  • China c.bank to skip open market operations on Thursday - statement
  • EU worker exodus threatens UK food industry, some leaving already - survey
  • Australia shares set to edge higher, NZ down
  • Firefighters battle blaze at store in east London
  • Trump, McConnell 'united on many shared priorities' -White House
  • Rotterdam incident not connected to attacks in Catalonia last week - source
  • Dyche concerned about player safety after Blackburn fan invades pitch
  • Russian ambassador to Sudan found dead in swimming pool
  • Rotterdam mayor says bus with gas bottles found outside cancelled concert
  • Detained driver of vehicle in Rotterdam incident is Spanish-El Pais
  • Southampton and Newcastle go out in League Cup, Burnley win derby
  • Republicans working with Trump on 'shared goals' -McConnell
  • Air strikes near Houthi checkpoint kill at least 35 in Yemen
  • Firefighters battle blaze at store in east London
Science & Technology Share

MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

MedGenome launches liquid biopsy blood test 'Oncotrack' for  cancer detection in patients

Mumbai, Mar 8 (UNI) MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for cancer recurrence detection and monitoring.
The Oncotrack is a non-invasive screening test that is set to transform the way physicians in India can identify genetic alterations, interpret, assess and treat various forms of cancers.
Launching the blood test yesterday, Chief operation officer of MedGenome, Dr V L Ramprasad said, 'Liquid biopsy has the capacity to interpret infinite mutations which will pave the way for new drug discovery, research and therapies.
Over 35 oncologists in India have already screened patients using our Oncotrack.
Further, since it has a very patient-friendly approach, we are confident it will be very well accepted by both the doctors and patients.
' India is likely to have over 1.
73 million new cases of cancer and over 8,80,000 deaths due to the disease by 2020.
Around 70 per cent of all cancer patients approach the doctor when the disease has advanced, and the chances of cure are very low.
'Management of cancer will undergo a massive transformation in India with NGS-based liquid biopsies.
We are constantly striving to get the most advanced genetic testing technology/ technique at affordable prices to the patients and Oncotrack is one such offering,' said Sam Santhosh, chairman, MedGenome.
The test, developed entirely by MedGenome, is the only one to be validated in India and verified from samples of cancer patients from across the country.
The test screens the samples by analyzing cell-free DNA that is isolated from the patients’ blood.
Using high-end sequencing technology, the screening process identifies specific gene mutations that are linked with Melanoma, Lung and Colon cancers.
The test facilitates detection of mutation where there is difficulty of obtaining biopsy or in the event of a damaged biopsy material and non-availability of tissue biopsy.
This offers oncologists the power to look for actionable alterations in a patient's treatment, management, without having to do an invasive biopsy or where biopsy is not an option.
Oncotrack is a proven molecular tool after histopathology diagnosis and detecting molecular changes at baseline and at the time of relapse in lung and colon cancer for deciding the right treatment.
The test has been validated in a scientific study, in academic collaboration with Tata Memorial Hospital -- Dr Kumar Prabhash, medical oncologist, and Dr Amit Dutt, principal investigator (Scientist F) at ACTREC, Tata Memorial Centre.
UNI ST SS RSA SB 1043

Dengue:

Dengue: 474 confirmed cases reported in Kalaburagi District

Kalaburagi, Aug 23 (UNI) The Health Department sources out of 1,927 suspected cases reported in the District, 474 have been confirmed as Dengue.

Low-weight

Low-weight & anaemic children, women decreases significantly in Bengal

Kolkata, Aug 23 (UNI) The number of low-weight and anaemic children under five years and women in the state are decreasing rapidly, according to a recent report by the Union Ministry of Women and Child Development.

Zydus Cadilla gets USFDAs final nod for Pindolol tablets

Mumbai, Aug 22 (UNI) Pharma Major, Zydus Cadila has received the final approval from the USFDA to market Pindolol Tablets USP, 5 mg and 10 mg.

Solar

Solar eclipse 2017: North America will witness total solar eclipse

New York, Aug 21 (UNI) Today, all of North America will witness a total solar eclipse for the first time in 99 years, where the Moon will pass in front of the Sun, casting darkness across swathes of the Earth's surface -- with up to 14 states shrouded in complete blackout.

Solar eclipse 2017: North America will witness total solar eclipse

Solar eclipse 2017: North America will witness total solar eclipse

New York, Aug 21 (UNI) Today, all of North America will witness a total solar eclipse for the first time in 99 years, where the Moon will pass in front of the Sun, casting darkness across swathes of the Earth's surface - with up to 14 states shrouded in complete blackout.

Nano-particle fertilizer could lead to new 'green revolution'

Nano-particle fertilizer could lead to new 'green revolution'

New Delhi, Jan 26 (UNI) Sri Lankan scientists report having developed a simple way to make a benign, more efficient fertilizer – described as nano-particle fertilizer - that could contribute to a second food revolution across the globe.

Broken pebbles offer clues to Palaeolithic funeral rituals

Broken pebbles offer clues to Palaeolithic funeral rituals

New Delhi, Feb 9 (UNI) Humans may have ritualistically "killed" objects to remove their symbolic power, some 5,000 years earlier than previously thought, a new international study of marine pebble tools from an Upper Palaeolithic burial site in Italy suggests.

image